PACS Group (NYSE:PACS) Now Covered by Stephens

Stephens started coverage on shares of PACS Group (NYSE:PACS - Free Report) in a report issued on Monday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $31.00 price objective on the stock.

A number of other equities analysts also recently commented on PACS. Citigroup started coverage on shares of PACS Group in a research note on Monday. They set a buy rating and a $32.00 target price for the company. JPMorgan Chase & Co. started coverage on shares of PACS Group in a research note on Monday. They set an overweight rating and a $27.00 target price for the company. Royal Bank of Canada started coverage on shares of PACS Group in a research note on Monday. They set an outperform rating and a $30.00 target price for the company. Truist Financial initiated coverage on shares of PACS Group in a research note on Monday. They set a buy rating and a $32.00 target price for the company. Finally, Oppenheimer initiated coverage on shares of PACS Group in a research report on Monday. They issued an outperform rating and a $31.00 price target for the company. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, PACS Group presently has an average rating of Buy and a consensus target price of $30.50.

View Our Latest Report on PACS Group


PACS Group Stock Performance

Shares of NYSE:PACS traded up $0.12 during trading on Monday, hitting $24.93. The company's stock had a trading volume of 272,758 shares, compared to its average volume of 677,316. PACS Group has a fifty-two week low of $22.61 and a fifty-two week high of $25.72.

Insider Activity at PACS Group

In other news, CEO Jason Hulse Murray sold 1,607,142 shares of the company's stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $21.00, for a total value of $33,749,982.00. Following the completion of the sale, the chief executive officer now directly owns 62,754,551 shares of the company's stock, valued at $1,317,845,571. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

About PACS Group

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Featured Stories

Analyst Recommendations for PACS Group (NYSE:PACS)

Should you invest $1,000 in PACS Group right now?

Before you consider PACS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.

While PACS Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Featured Articles and Offers

Search Headlines: